(S1 (S (NP (NP (JJ Inhibitory) (NN effect)) (PP (IN of) (NP (NN citral))) (PP (IN on) (NP (NP (NN NO) (NN production)) (PP (IN by) (NP (NP (NP (NN suppression)) (PP (IN of) (NP (NN iNOS) (NN expression)))) (CC and) (NP (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN in) (NP (NN RAW264.7) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NN Citral)) (VP (VBZ is) (NP (NP (DT a) (JJ major) (NN compound)) (PP (IN of) (NP (NP (NNS lemongrass)) (PRN (-LRB- -LRB-) (NP (NNP Cymbopogon) (FW citratus) (FW L.)) (-RRB- -RRB-)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (NP (NP (JJ many) (JJ pharmacological) (NNS activities)) (PP (JJ such) (IN as) (NP (ADJP (ADJP (JJ anti-fungal)) (CC and) (ADJP (JJ anti-bacterial))) (NNS effects)))))))))) (. .)))
(S1 (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VP (VBD investigated) (NP (NP (DT the) (JJ anti-inflammatory) (NN effect)) (PP (IN of) (NP (NN citral))))) (CC and) (VP (VBD defined) (NP (NP (PRP$ its) (NN mechanism)) (PP (IN of) (NP (NN action))) (PP (IN in) (NP (ADJP (NN lipopolysaccharide) (-LRB- -LRB-) (NN LPS) (-RRB- -RRB-) (JJ -stimulated)) (NN RAW) (CD 264.7) (NNS cells)))))) (. .)))
(S1 (S (S (NP (NP (NN Citral)) (PRN (-LRB- -LRB-) (NP (CD 3-12) (NN microg/mL)) (-RRB- -RRB-))) (ADVP (RB significantly)) (VP (VBD inhibited) (NP (NP (JJ LPS-induced) (NP (NP (JJ nitric) (NN oxide)) (PRN (-LRB- -LRB-) (NP (NN NO)) (-RRB- -RRB-))) (NN production)) (PP (IN in) (NP (NP (DT a) (JJ concentration-dependent) (NN manner)) (PRN (-LRB- -LRB-) (NP (NN IC50) (: :) (CD 6.5) (NN microg/mL)) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (NN citral)) (ADVP (RB effectively)) (VP (VP (VBD inhibited) (NP (NP (DT the) (JJ transcriptional) (NN activity)) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP (NN iNOS)))))) (, ,) (CC and) (ADVP (RB potently)) (VP (VBD suppressed) (NP (NP (DT the) (NN DNA) (NN binding) (NN activity)) (CC and) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN I) (NN kappa) (NN B)) (NN phosphorylation))) (PP (IN in) (NP (DT a) (ADJP (NN concentration) (JJ dependent)) (NN manner)))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (S (NP (NN citral)) (VP (VBZ is) (ADJP (JJ anti-inflammatory)))) (, ,) (CC and) (S (NP (PRP$ its) (NNS effects)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN NO) (NN production)))))) (PP (IN through) (NP (NP (DT the) (NN suppression)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))))))))))) (. .)))
